SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea · Delayed Price · Currency is KRW 1,600.00
+5.00 (0.31%)
Last updated: Oct 2, 2025, 9:00 AM KST
SAMSUNG PHARM. Co., LTD. Market Cap
SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 150.12 billion as of October 6, 2025. Its market cap has increased by 3.24% in one year.
Market Cap
150.12B
Enterprise Value
n/a
Revenue
44.29B
Ranking
n/a
PE Ratio
11.81
Stock Price
1,600.00
Market Cap Chart
Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 150.12B, an increase of 739.38%. That is a compound annual growth rate of 7.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 150.12B | 3.71% |
| Dec 30, 2024 | 144.76B | -0.84% |
| Dec 28, 2023 | 145.99B | -18.99% |
| Dec 29, 2022 | 180.22B | -45.48% |
| Dec 30, 2021 | 330.57B | -11.17% |
| Dec 30, 2020 | 372.12B | 50.47% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |